Nicotine replacement therapies: patient safety and persistence
Stuart G Ferguson1,2, Saul Shiffman3,4, Joseph G Gitchell51School of Pharmacy, 2Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia; 3Pinney Associates, 4University of Pittsburgh, Pittsburgh, PA, USA; 5Pinney Associates, Bethesda, MD, USAAbstract: Nicotine replacement ther...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-06-01
|
Series: | Patient Related Outcome Measures |
Online Access: | http://www.dovepress.com/nicotine-replacement-therapies-patient-safety-and-persistence-a7642 |
id |
doaj-4d28dc993c71416ba01036f4b6370e45 |
---|---|
record_format |
Article |
spelling |
doaj-4d28dc993c71416ba01036f4b6370e452020-11-24T22:23:48ZengDove Medical PressPatient Related Outcome Measures1179-271X2011-06-012011default111117Nicotine replacement therapies: patient safety and persistenceFerguson SGShiffman SGitchell JGStuart G Ferguson1,2, Saul Shiffman3,4, Joseph G Gitchell51School of Pharmacy, 2Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia; 3Pinney Associates, 4University of Pittsburgh, Pittsburgh, PA, USA; 5Pinney Associates, Bethesda, MD, USAAbstract: Nicotine replacement therapy (NRT) has become a central part of the treatment of nicotine dependence. However, NRT’s potential efficacy is limited to some extent by patient adherence and persistence. Here we review the relationship between NRT compliance and adherence, and overall treatment outcome. We then examine the factors that likely impact on treatment compliance and persistence, with a special focus on users’ perceptions of treatment safety and efficacy as possible mediators. Potential clinical strategies for improving suboptimal medication use are also discussed.Keywords: nicotine replacement therapy, compliance, safetyhttp://www.dovepress.com/nicotine-replacement-therapies-patient-safety-and-persistence-a7642 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ferguson SG Shiffman S Gitchell JG |
spellingShingle |
Ferguson SG Shiffman S Gitchell JG Nicotine replacement therapies: patient safety and persistence Patient Related Outcome Measures |
author_facet |
Ferguson SG Shiffman S Gitchell JG |
author_sort |
Ferguson SG |
title |
Nicotine replacement therapies: patient safety and persistence |
title_short |
Nicotine replacement therapies: patient safety and persistence |
title_full |
Nicotine replacement therapies: patient safety and persistence |
title_fullStr |
Nicotine replacement therapies: patient safety and persistence |
title_full_unstemmed |
Nicotine replacement therapies: patient safety and persistence |
title_sort |
nicotine replacement therapies: patient safety and persistence |
publisher |
Dove Medical Press |
series |
Patient Related Outcome Measures |
issn |
1179-271X |
publishDate |
2011-06-01 |
description |
Stuart G Ferguson1,2, Saul Shiffman3,4, Joseph G Gitchell51School of Pharmacy, 2Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia; 3Pinney Associates, 4University of Pittsburgh, Pittsburgh, PA, USA; 5Pinney Associates, Bethesda, MD, USAAbstract: Nicotine replacement therapy (NRT) has become a central part of the treatment of nicotine dependence. However, NRT’s potential efficacy is limited to some extent by patient adherence and persistence. Here we review the relationship between NRT compliance and adherence, and overall treatment outcome. We then examine the factors that likely impact on treatment compliance and persistence, with a special focus on users’ perceptions of treatment safety and efficacy as possible mediators. Potential clinical strategies for improving suboptimal medication use are also discussed.Keywords: nicotine replacement therapy, compliance, safety |
url |
http://www.dovepress.com/nicotine-replacement-therapies-patient-safety-and-persistence-a7642 |
work_keys_str_mv |
AT fergusonsg nicotinereplacementtherapiespatientsafetyandpersistence AT shiffmans nicotinereplacementtherapiespatientsafetyandpersistence AT gitchelljg nicotinereplacementtherapiespatientsafetyandpersistence |
_version_ |
1725763828885487616 |